Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review

Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review

Asthma is a heterogeneous chronic inflammatory condition affecting the lung. Standard treatment, a high-dose inhaled corticosteroid (ICS) and long-acting bronchodilator (LABA), effectively manages asthma in most individuals. However, 5%-10% of individuals with asthma were ineffective with those tre...

Full description

Bibliographic Details
Main Authors:	Evelyn Evelyn, Putra Brillian Djohan, Fauna Herawati
Format:	Article
Language:	English
Published:	Universitas Nahdlatul Ulama Surabaya 2022-11-01
Series:	Jurnal Ilmiah Kesehatan
Online Access:	https://journal2.unusa.ac.id/index.php/JHS/article/view/2788

Similar Items

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma
by: Castro, M, et al.
Published: (2018)

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis
by: Maspero, JF, et al.
Published: (2019)

Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study
by: Castro, M, et al.
Published: (2018)

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma
by: Castro, M, et al.
Published: (2018)

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
by: Guilbert TW, et al.
Published: (2024-03-01)

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
by: Mario Castro, et al.
Published: (2020-01-01)

Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
by: Makoto Hoshino, et al.
Published: (2022-10-01)

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
by: Corren J, et al.
Published: (2023-03-01)

Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
by: Mohamed Sayed Zaazouee, et al.
Published: (2022-10-01)

Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
by: Yuji Tohda, et al.
Published: (2023-01-01)

Efficacy of tezepelumab against uncontrolled severe non‐type 2 asthma refractory to bronchial thermoplasty, benralizumab, dupilumab and mepolizumab
by: Yoshiro Kai, et al.
Published: (2024-03-01)

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma
by: Busse, WW, et al.
Published: (2018)

Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST
by: Wenzel, SE, et al.
Published: (2018)

Severe pediatric asthma therapy: Dupilumab
by: Giuliana Ferrante, et al.
Published: (2022-11-01)

Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS)
by: Stanley J. Szefler, et al.
Published: (2022-07-01)

Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis
by: Mahmoud Shaban Abdelgalil, et al.
Published: (2022-12-01)

Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study
by: Maspero, J, et al.
Published: (2018)

The Role of Dupilumab in Severe Asthma
by: Fabio Luigi Massimo Ricciardolo, et al.
Published: (2021-08-01)

Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China
by: You Li, et al.
Published: (2024-12-01)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
by: Lucia De Prado Gomez, et al.
Published: (2023-03-01)

Azithromycin in uncontrolled asthma
by: Brusselle, G, et al.
Published: (2017)

ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN
by: V. I. Petrov, et al.
Published: (2015-03-01)

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma
by: Jonathan Corren, et al.
Published: (2023-10-01)

Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
by: Zoumot Z, et al.
Published: (2022-11-01)

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose
by: Christian Domingo, et al.
Published: (2023-11-01)

Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
by: Eugene R. Bleecker, et al.
Published: (2023-01-01)

Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma
by: Serafeim-Chrysovalantis Kotoulas, et al.
Published: (2023-07-01)

Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP
by: Giancarlo Ottaviano, et al.
Published: (2023-08-01)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
by: Mara Giavina-Bianchi, et al.
Published: (2021-05-01)

Risk factors for uncontrolled asthma in adults
by: Juan Carlos Fernández de Córdova-Aguirre, et al.
Published: (2019-04-01)

Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma
by: Trivedi, A, et al.
Published: (2016)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
by: Laidlaw TM, et al.
Published: (2023-09-01)

Clinical efficacy of anti-ige-therapy in adult patients with severe uncontrolled bronchial asthma in real clinical practice
by: G. L. Ignatova, et al.
Published: (2018-10-01)

Efficacy and safety of subliminal transscleral cyclophotocoagulation in uncontrolled glaucoma
by: Ferzana Mohammed, et al.
Published: (2022-01-01)

Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthma
by: Dave Singh, et al.
Published: (2023-05-01)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
by: Dong Hyek Jang, et al.
Published: (2020-06-01)

Montelukast As An Add On Therapy In Asthma As Compared To Its Use In Asthma Associated With Concomitant Rhinitis Symptoms
by: kassim M. Sultan
Published: (2011-07-01)

Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
by: Yuka Shibata, et al.
Published: (2021-08-01)

Successful treatment with dupilumab for mucus plugs in severe asthma
by: Moriyasu Anai, et al.
Published: (2023-01-01)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
by: Beatrice Ragnoli, et al.
Published: (2022-05-01)